Sponsor

Centre for Addiction and Mental Health

Clinical research sponsor

Published trials165
Recruiting shown16
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
Theta-Burst Stimulation to Treat DepressionNCT07033780 · lead sponsor · 2025-06-01
RECRUITING
Magnetic Seizure Therapy for Schizophrenia - TrialNCT06672588 · lead sponsor · 2025-04-22
RECRUITING
Accelerated vs. Conventional Theta Burst Stimulation for Late-life DepressionNCT06854367 · lead sponsor · 2025-03-27
RECRUITING
Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive ImpairmentNCT06780917 · lead sponsor · 2025-01-13
RECRUITING
Nature-based Virtual Reality Intervention for Depression in Alzheimer's DiseaseNCT06732128 · lead sponsor · 2025-01-06
RECRUITING
TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)NCT06783283 · lead sponsor · 2025-01-02
RECRUITING
Technology-Enabled Collaborative Care for Young Adults With Type 1 Diabetes and Diabetes Distress: A Feasibility TrialNCT06804694 · lead sponsor · 2024-11-27
RECRUITING
Presynaptic Imaging in Major Depressive Episodes After COVID-19NCT06086366 · lead sponsor · 2023-08-22
RECRUITING
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual DisabilityNCT05744479 · lead sponsor · 2023-02-28
RECRUITING
Effects of NAC on Symptoms of CHR PatientsNCT05142735 · lead sponsor · 2023-01-13
RECRUITING
E-field Guided iTBS for Treatment Resistant DepressionNCT05583747 · lead sponsor · 2022-10-24
RECRUITING
"Extended" (Alternate Day) Antipsychotic DosingNCT04478838 · lead sponsor · 2022-06-06
RECRUITING
Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled TrialNCT05142683 · lead sponsor · 2022-02-01
RECRUITING
Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in DepressionNCT04935619 · lead sponsor · 2021-07-21
RECRUITING
rTMS for Depression in Young Adults With AutismNCT04972136 · lead sponsor · 2021-01-14
RECRUITING
Switching From Twice-Daily to Once-Daily Clozapine Dosing in SchizophreniaNCT02639702 · lead sponsor · 2016-10-15
RECRUITING
Group Dialectical Behaviour Therapy (DBT) Skills Training for First Episode PsychosisNCT07777315 · lead sponsor · 2026-09-15
NOT_YET_RECRUITING
Identifying Biomarkers of Response to Digital Interventions for Mood DisordersNCT07783633 · lead sponsor · 2026-07-28
ENROLLING_BY_INVITATION
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use DisorderNCT07405606 · lead sponsor · 2026-03-01
NOT_YET_RECRUITING
Effects of Antipsychotics on Brain Insulin Action in FemalesNCT06251635 · lead sponsor · 2024-06-03
ACTIVE_NOT_RECRUITING
Investigating the Muscarinic System in Schizophrenia Using Positron Emission TomographyNCT06278246 · lead sponsor · 2024-03-11
ACTIVE_NOT_RECRUITING
Racial Disparities in Antidepressant Treatment After a Psychiatric ConsultationNCT06799078 · lead sponsor · 2024-03-04
ACTIVE_NOT_RECRUITING
The Effects of Non-invasive Neuromodulation on Illness Awareness in SchizophreniaNCT05957484 · lead sponsor · 2023-09-12
TERMINATED
Optimizing Mental Health for Young People at Clinical High Risk for Psychosis (CHR)NCT05757128 · lead sponsor · 2023-08-24
COMPLETED
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in SchizophreniaNCT05748990 · lead sponsor · 2023-04-01
ACTIVE_NOT_RECRUITING
Risk of Breakthrough Symptoms With Long-Acting Injectable MedicationsNCT05473741 · lead sponsor · 2023-01-11
COMPLETED
A Remote Electronically Delivered Integrated Care Pathway: A Feasibility StudyNCT05086120 · lead sponsor · 2023-01-04
TERMINATED
Microglial Activation in Inflammatory Bowel DiseaseNCT03487926 · lead sponsor · 2022-09-14
COMPLETED
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and ObesityNCT05333003 · lead sponsor · 2022-05-25
ACTIVE_NOT_RECRUITING
rTMS for Suicidality in Opioid Use DisorderNCT04785456 · lead sponsor · 2022-03-01
COMPLETED
Community Reinforcement Approach and Family Training for Substance Use in Early Psychosis InterventionNCT05300633 · lead sponsor · 2022-02-08
COMPLETED
Cognitive Dysfunction in the Addictions Study - Project 4 (P4)NCT06299787 · lead sponsor · 2022-02-07
UNKNOWN
PrEP and Alcohol - Enhancing HIV Pre-Exposure Prophylaxis (PrEP)NCT05097430 · lead sponsor · 2021-09-28
COMPLETED
Does tDCS Change Synaptic Density in the Brains of Patients With SchizophreniaNCT05435300 · lead sponsor · 2021-09-17
ACTIVE_NOT_RECRUITING
A Pilot Trial of Nabilone for the Treatment of ObesityNCT04801641 · lead sponsor · 2021-09-17
TERMINATED
Is Brain Insulin Resistance a Feature of the Biology of Depression in AdolescentsNCT05571878 · lead sponsor · 2021-09-01
COMPLETED
Neuroinflammation in COVID-19 and DepressionNCT04854785 · lead sponsor · 2021-06-14
COMPLETED
Technology-enabled Collaborative Care for Diabetes Management During COVID-19NCT04607915 · lead sponsor · 2021-05-04
COMPLETED
MAO-B Occupancy in Depressed PatientsNCT04841798 · lead sponsor · 2021-04-15
COMPLETED
Brief Digital CBT for Mood and Anxiety Symptoms in Acute Psychiatric InpatientsNCT04841603 · lead sponsor · 2021-04-12
COMPLETED
Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider EngagementNCT04602741 · lead sponsor · 2021-01-04
COMPLETED
Non-Inferiority RCT Comparing Online and On-Site CBT in MDDiNCT04825535 · lead sponsor · 2020-12-15
WITHDRAWN
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum DisordersNCT04418011 · lead sponsor · 2020-11-30
COMPLETED
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis InterventionNCT04298450 · lead sponsor · 2020-09-21
COMPLETED
Accelerated iTBS for Depressed Patients During the COVID-19 PandemicNCT04384965 · lead sponsor · 2020-05-12
COMPLETED
High Dose Accelerated iTBS for DepressionNCT04255784 · lead sponsor · 2020-02-06
COMPLETED
Early Psychosis Intervention - Spreading Evidence-based TreatmentNCT03919760 · lead sponsor · 2020-01-03
COMPLETED
A Study of Cognitive Adaptation Training in Inpatient Forensic EnvironmentsNCT04294719 · lead sponsor · 2019-12-12
COMPLETED
The Effects of Non-invasive Brain Stimulation on Treatment Adherence in SchizophreniaNCT04033679 · lead sponsor · 2019-08-15
ACTIVE_NOT_RECRUITING
RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)NCT05531591 · lead sponsor · 2019-08-01
COMPLETED
Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCSNCT03846492 · lead sponsor · 2019-04-24
ACTIVE_NOT_RECRUITING
Online Writing Intervention for Major Depressive DisorderNCT06699719 · lead sponsor · 2019-03-27
COMPLETED
Reactivity of the Vestibular System to Caloric Vestibular Stimulation in SchizophreniaNCT03048370 · lead sponsor · 2019-01-01
COMPLETED
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in DementiaNCT03672201 · lead sponsor · 2018-11-01
ACTIVE_NOT_RECRUITING
Cognitive Remediation Therapy for Participants With Late-Life SchizophreniaNCT03695614 · lead sponsor · 2018-10-24
COMPLETED
Efficacy of Convulsive Therapies During ContinuationNCT03711019 · lead sponsor · 2018-10-22
COMPLETED
Maintenance of Response After rTMS for Depression Using tDCSNCT03708159 · lead sponsor · 2018-09-24
COMPLETED
Technology-Enabled Collaborative Care for YouthNCT03610087 · lead sponsor · 2018-07-25
COMPLETED
MARt-Depression TrialNCT03564067 · lead sponsor · 2018-07-05
COMPLETED
Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of DementiaNCT03638284 · lead sponsor · 2018-07-05
COMPLETED

Sponsor roles

lead sponsor131
collaborator34

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.